EPCAM and Familial prostate cancer: Ag-decorated nanorods conjugated with anti-EpCAM antibodies and chemotherapy agents, selectively bound PC3 prostate cancer cells, and enabled the tracking of the nanorod conjugates via SERS microscopy, while simultaneously delivering chemotherapeutics to the cells [113].